Wrap Text
LHFI - Notification of Voting Results
LIFE HEALTHCARE FUNDING LIMITED
(Incorporated in the Republic of South Africa)
Registration number: 2016/273566/06
Bond company code: LHFI
('Life Healthcare Funding' or the 'Issuer')
NOTIFICATION OF THE VOTING RESULTS IN RESPECT OF THE REQUEST FOR EXTRAORDINARY RESOLUTIONS FROM THE HOLDERS OF ALL THE NOTES
ISSUED UNDER THE ISSUER'S R 7 000 000 000 DOMESTIC MEDIUM TERM NOTE PROGRAMME
Noteholders are referred to the notice of a meeting of the holders of all the notes (the 'Notes'), issued by the Issuer under the Issuer's Domestic Medium Term Note
Programme (the 'Programme'), released on SENS on 6 October 2023, in relation to the amendment and restatement of the Programme pursuant to which certain of the
terms and conditions in the Programme will be amended, the amendment and restatement of the Guarantee and the release of a Guarantor under the Programme from its
obligations as a guarantor under the Guarantee and the Programme.
The following Extraordinary Resolutions were included in the notice of the meeting for consideration by the holders of all the Notes:
- Extraordinary resolution 1:
THAT the Issuer is authorised to amend Condition 8 of the Terms and Conditions of the Notes pursuant to the correction of the wording in clause 8.1, the correction of the
wording in clause 8.5.1; and the inclusion of a new clause 8.6;
- Extraordinary resolution 2:
THAT the Issuer is authorised to amend the terms and conditions of the Guarantee, as contained under the section of the Programme Memorandum entitled 'Terms and
Conditions of the Guarantee', pursuant to the inclusion of a new recordal at the beginning of the Guarantee for purposes of addressing the amendment and restatement of
the terms and conditions of the Guarantee; the amendment of the references to the Programme Memorandum in the Guarantee to record the amendment and restatement
of the Programme Memorandum; the correction of the wording in clause 12.2; and the inclusion of new clauses 22 and 23 respectively;
- Extraordinary resolution 3:
THAT subject to the passing of Extraordinary Resolutions 1 and 2 above, and in conjunction with this resolution, the Issuer is authorised to amend the terms and conditions
of the Programme Memorandum pursuant to the issue of an amended and restated Programme Memorandum to reflect, inter alia, the amendments set out in
Extraordinary Resolutions 1 and 2 respectively as well as to update, inter alia, various references to, inter alia, the dates of execution of the Programme Memorandum and
the Guarantee respectively;
- Extraordinary resolution 4:
THAT subject to the passing of Extraordinary Resolutions 1 to 3, and in conjunction with this resolution, the Issuer is authorised to amend the terms and conditions of the
Guarantee pursuant to the inclusion of a new recordal at the beginning of the Guarantee, for purposes of addressing the amendment and restatement of the terms and
conditions of the Guarantee; the amendment of the references to the Programme Memorandum in the Guarantee in order to record the amendment and restatement of the
Programme Memorandum; the correction of the wording in clause 12.2; and the inclusion of new clauses 22 and 23 respectively; and
- Extraordinary resolution 5:
THAT subject to the passing of Extraordinary Resolutions 1 to 4 (both inclusive) as well as this resolution, Alliance Medical Limited ('AML') is to be released from its
obligations as Guarantor under the Programme and in particular as Guarantor under the Guarantee with effect from the date on which the Disposal occurs and from such
date, all references within the Programme Memorandum, the Guarantee and any Applicable Pricing Supplement, as the case may be, to AML, will be null and void and will
be deemed, for all intents and purposes, to be removed from the Programme Memorandum, the Guarantee and all Applicable Pricing Supplements currently in issue, in
totality, without requiring any further steps, actions, supplements, agreements or amendments whatsoever having to be effected to either the Programme and/or the
Guarantee and/or any Applicable Pricing Supplement, as the case may be, by the Issuer and/or any Noteholder whatsoever and AML will be released as Guarantor under
the Programme.
In this regard, the Issuer confirms the voting results from the consent request in relation to the total nominal amount of the LHC01 and LHC02 Notes in issue are as
follows:
Extraordinary Total nominal Debt securities Debt securities Votes abstained, as Votes carried for Votes against the
Resolutions amount of debt voted, disclosed as voted, disclosed a percentage the resolution, as a resolution, as a
securities in issue a number as a percentage percentage percentage
1 R 1 000 000 000.00 R 823 700 000.00 82.37% 0% 100% 0%
2 R 1 000 000 000.00 R 823 700 000.00 82.37% 0% 100% 0%
3 R 1 000 000 000.00 R 823 700 000.00 82.37% 0% 100% 0%
4 R 1 000 000 000.00 R 823 700 000.00 82.37% 0% 100% 0%
5 R 1 000 000 000.00 R 823 700 000.00 82.37% 0% 100% 0%
Life Healthcare Funding confirms that the extraordinary resolutions have accordingly been passed by the requisite number of the holders of the Notes.
30 October 2023
Debt sponsor
RAND MERCHANT BANK (a division of FirstRand Bank Limited)
Date: 30-10-2023 10:00:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
Sharenet Sites 
